Thymmune Therapeutics
Cambridge, MA
Thymmune Therapeutics is a preclinical biotechnology company based in Cambridge, MA applying proprietary insights in thymic engineering to develop and commercialize immune cell therapy products addressing significant opportunities with unmet clinical need across immunology. Building on work from leading labs, Thymmune has strong IP positioning and is backed by early investors and founders of successful high-profile biotechnology companies.
thymmune.comCompany Details
Founded
- 2019
Employees
- Between 5 - 20 employees
Raised
- $44,000,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Stan Wang
Founders
- Stan Wang
Company Collections
These are collections Thymmune Therapeutics is a part of. Click on the collection name to view similar companies.
Thymmune Therapeutics' Industries
Thymmune Therapeutics Headquarters Location
Total Amount Raised: $44,000,000
Thymmune Therapeutics Funding Rounds
Grant
$37,000,000
Grant Investors
Advanced Research Projects Agency for Health (ARPA-H)Seed
$7,000,000
Seed Investors
Pillar VCMark R. BamforthGeorge ChurchJohn MaraganorePhilip ReillyJudy PagliucaNYBC VenturesArranta Bio
Thymmune Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Thymmune Therapeutics.